EUVIMEDEUVIMED entdecken
Crossref

Aflibercept Loaded Eye‐Drop Hydrogel Mediated with Cell‐Penetrating Peptide for Corneal Neovascularization Treatment

Jianan Zhou, Yuting Cai, Tingting Li, Haixiang Zhou, Huilei Dong, Xia Wu, Zenghui Li, Wenjie Wang, Dan Yuan, Yun Li, Junfeng Shi iD

Small · 2024-01 · 20 (2)

DOI: 10.1002/smll.202302765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 07.09.2023. Verfasst von Jianan Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, School of Biomed…. Hauptthemen laut MEDLINE: Corneal Neovascularization, Cell-Penetrating Peptides, Recombinant Fusion Proteins, Receptors, Vascular Endothelial Growth Factor. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan, Science and Technology and Development Foundation of Shenzhen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal neovascularization (CoNV) is a major cause of visual impairment worldwide. Currently, available treatment options have limited efficacy and are associated with adverse effects due to biological barriers and clearance mechanisms. To address this challenge, a novel topical delivery system is developed—Gel 2_1&Eylea —an aflibercept‐loaded eye‐drop hydrogel mediated with cell‐penetrating peptide 1 . Gel 2_1&Eylea demonstrates superior membrane permeability, increased stability, and prolonged drug retention time on the ocular surface, and thus may improve drug efficacy. In a rabbit CoNV model, Gel 2_1&Eylea significantly reduces the density of neovascularization with no adverse effects on normal corneoscleral limbal vessels, demonstrating high efficacy and biocompatibility. This work identifies a promising treatment for CoNV which has the potential to benefit other ocular neovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Corneal NeovascularizationCell-Penetrating PeptidesRecombinant Fusion ProteinsReceptors, Vascular Endothelial Growth FactorAnimalsRabbitsHydrogelsOphthalmic Solutions

Stichwörter der Autor:innen

cell penetrating peptidecorneal neovascularizationpeptide hydrogelself-assembly

Substanzen

afliberceptCell-Penetrating PeptidesHydrogelsOphthalmic SolutionsRecombinant Fusion ProteinsReceptors, Vascular Endothelial Growth Factor

Autor:innen und Institutionen

  • Hunan Provincial Key Laboratory of Animal Models and Molecular Medicine, State Key Laboratory of Chemo/Bio-Sensing and Chemometrics, School of Biomedical Sciences, Hunan University, Changsha, Hunan, 410082, China.
  • Department of Ophthalmology, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.
  • Shenzhen International Institute for Biomedical Research, Longhua District, Shenzhen, Guangdong, 518116, China.

ORCID-Profile: Junfeng Shi

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan
  • Science and Technology and Development Foundation of Shenzhen
  • Hunan Provincial Health Commission grant
  • Natural Science Foundation of Changsha
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Zhou, J., Cai, Y., Li, T., Zhou, H., Dong, H., Wu, X., Li, Z., Wang, W., Yuan, D., Li, Y., & Shi, J. (2024). Aflibercept Loaded Eye‐Drop Hydrogel Mediated with Cell‐Penetrating Peptide for Corneal Neovascularization Treatment. Small, 20(2). https://doi.org/10.1002/smll.202302765

Vancouver

Zhou J, Cai Y, Li T, Zhou H, Dong H, Wu X, et al. Aflibercept Loaded Eye‐Drop Hydrogel Mediated with Cell‐Penetrating Peptide for Corneal Neovascularization Treatment. Small. 2024;20(2). doi:10.1002/smll.202302765

BibTeX
@article{Zhou2024,
  author = {Zhou, Jianan and Cai, Yuting and Li, Tingting and Zhou, Haixiang and Dong, Huilei and Wu, Xia and Li, Zenghui and Wang, Wenjie and Yuan, Dan and Li, Yun and Shi, Junfeng},
  title = {Aflibercept Loaded Eye‐Drop Hydrogel Mediated with Cell‐Penetrating Peptide for Corneal Neovascularization Treatment},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {2},
  doi = {10.1002/smll.202302765}
}
Kostenlos starten →